CALMARE THERAPEUTICS Inc company info

CIK 102198
IRS Number 362664428
State of incorporation DE
Business address 1375 KINGS HIGHWAY EAST
None
FAIRFIELD
CT
06824
Mail address 1375 KINGS HIGHWAY EAST
None
FAIRFIELD
CT
06824

Short summary

CALMARE THERAPEUTICS Inc is a Connecticut company, with head office located at 1375 Kings Highway East Fairfield, Connecticut 06824. In 2016 the company owned a total of 3.88 million USD worth of assets, including 3.86 million USD worth of current assets. 2010 was the year when the company amassed the most assets.

CALMARE THERAPEUTICS Inc Income Statement

Name [in Millions USD]20092010201120122013201420152016Trends
Revenue, Net 3.33
Gross Profit 1.860.550.380.600.610.79
Operating Expenses 5.583.710.151.180.981.43
Operating Income (Loss) -2.52-2.23-2.70-2.39
Interest expense 0.040.080.210.960.981.43
Income Tax Expense (Benefit)
Net income -3.60-3.00-2.67-3.41-3.68-3.83

CALMARE THERAPEUTICS Inc Balance Sheet

Name [in Millions USD]20092010201120122013201420152016Trends
Cash and cash equivalents 1.080.320.020.020.020.080.130.01
Accounts Receivable, Net, Current 0.040.020.1300.00
Inventories 4.214.364.124.003.95
Property, Plant and Equipment, Gross 0.230.180.220.220.220.22
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.20-0.160.170.190.200.21
Total assets 5.274.664.484.494.324.123.88
Current assets 5.224.604.454.434.284.093.86
Accounts payable 0.151.861.810.881.721.642.09
Total current liabilities 5.297.439.7910.8613.1416.1417.70
Total liabilities 6.779.7910.43
Common Stock, Value, Issued 0.140.150.160.240.280.290.29
Retained Earnings (Accumulated Deficit) -44.32-48.34-51.07-53.80-57.48-61.36-63.20

CALMARE THERAPEUTICS Inc Cash Flow

Name [in Millions USD]20092010201120122013201420152016Trends
Net income -3.60-3.00-2.67-3.41-3.68-3.83
Depreciation 0.020.01
Depreciation and amortization 0.020.010.010.020.020.02
Inventories -2.480.15-0.09-0.16-0.09-0.19
Deferred revenue 0.01-0.00-0.000.01-0.01
Net Cash Provided by (Used in) Operating Activities -1.19-1.37
Payments to Acquire Property, Plant, and Equipment -0.010.020.050.00
Net Cash Provided by (Used in) Investing Activities 0.03-0.02
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.02-0.05-0.00
Proceeds from Issuance of Long-term Debt 0.20
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.030.000.000.00
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.030.000.000.00
Proceeds from Issuance of Common Stock 0.53
Net Cash Provided by (Used in) Financing Activities 0.641.44
Cash and Cash Equivalents, Period Increase (Decrease) -0.530.05-0.02-0.050.04-0.04